OTC Markets in India 2008-09
-
Upload
neelesh-bhandari -
Category
Travel
-
view
3.636 -
download
2
Transcript of OTC Markets in India 2008-09
![Page 1: OTC Markets in India 2008-09](https://reader035.fdocuments.net/reader035/viewer/2022062418/555ade69d8b42a024a8b51e5/html5/thumbnails/1.jpg)
OTC Market in India
![Page 2: OTC Markets in India 2008-09](https://reader035.fdocuments.net/reader035/viewer/2022062418/555ade69d8b42a024a8b51e5/html5/thumbnails/2.jpg)
• Population - 1.1 Billion
• GDP - 1,170,968 million USD
• GDP growth rate - 9%
• Gross national income per capita (PPP international $): 2,460
• Total expenditure on health per capita(Intl $, 2006): 109
• Total expenditure on health as % of GDP(2006): 4.9
Source: World Health Statistics 2008
![Page 3: OTC Markets in India 2008-09](https://reader035.fdocuments.net/reader035/viewer/2022062418/555ade69d8b42a024a8b51e5/html5/thumbnails/3.jpg)
• 700 million people have no access to specialist care
• 80% of specialists live in urban areas
![Page 4: OTC Markets in India 2008-09](https://reader035.fdocuments.net/reader035/viewer/2022062418/555ade69d8b42a024a8b51e5/html5/thumbnails/4.jpg)
• Currently the Indian OTC market (i.e. advertised non-prescription medicines) is estimated to represent approximately USD 1,793 million
• OTC sales account for about 18% of total pharmaceutical sales
![Page 5: OTC Markets in India 2008-09](https://reader035.fdocuments.net/reader035/viewer/2022062418/555ade69d8b42a024a8b51e5/html5/thumbnails/5.jpg)
![Page 6: OTC Markets in India 2008-09](https://reader035.fdocuments.net/reader035/viewer/2022062418/555ade69d8b42a024a8b51e5/html5/thumbnails/6.jpg)
Private health expenditure as percentage of GDP
![Page 7: OTC Markets in India 2008-09](https://reader035.fdocuments.net/reader035/viewer/2022062418/555ade69d8b42a024a8b51e5/html5/thumbnails/7.jpg)
Doctor patient ratio in India is 1:1700
![Page 8: OTC Markets in India 2008-09](https://reader035.fdocuments.net/reader035/viewer/2022062418/555ade69d8b42a024a8b51e5/html5/thumbnails/8.jpg)
![Page 9: OTC Markets in India 2008-09](https://reader035.fdocuments.net/reader035/viewer/2022062418/555ade69d8b42a024a8b51e5/html5/thumbnails/9.jpg)
30% of Beds for >70% of population
![Page 10: OTC Markets in India 2008-09](https://reader035.fdocuments.net/reader035/viewer/2022062418/555ade69d8b42a024a8b51e5/html5/thumbnails/10.jpg)
Most money spent on Vaccination and primary prevention.
![Page 11: OTC Markets in India 2008-09](https://reader035.fdocuments.net/reader035/viewer/2022062418/555ade69d8b42a024a8b51e5/html5/thumbnails/11.jpg)
Growth rate• Rural
12.75% • Urban
15.15%
![Page 12: OTC Markets in India 2008-09](https://reader035.fdocuments.net/reader035/viewer/2022062418/555ade69d8b42a024a8b51e5/html5/thumbnails/12.jpg)
![Page 13: OTC Markets in India 2008-09](https://reader035.fdocuments.net/reader035/viewer/2022062418/555ade69d8b42a024a8b51e5/html5/thumbnails/13.jpg)
Indian behavior in illness.
![Page 14: OTC Markets in India 2008-09](https://reader035.fdocuments.net/reader035/viewer/2022062418/555ade69d8b42a024a8b51e5/html5/thumbnails/14.jpg)
Datamonitor
Points of sale.
![Page 15: OTC Markets in India 2008-09](https://reader035.fdocuments.net/reader035/viewer/2022062418/555ade69d8b42a024a8b51e5/html5/thumbnails/15.jpg)
Datamonitor
![Page 16: OTC Markets in India 2008-09](https://reader035.fdocuments.net/reader035/viewer/2022062418/555ade69d8b42a024a8b51e5/html5/thumbnails/16.jpg)
“Maximum number of OTC drugs sold by qualified chemists and pharmacists are from branded companies like Pfizer Inc., share of which is estimated at about 8%, followed by Sanofi-Aventis 7% and Johnson & Johnson 5.5%..”
-Assocham study, 2008.
The Associated Chambers of Commerce and Industry of India (ASSOCHAM)
![Page 17: OTC Markets in India 2008-09](https://reader035.fdocuments.net/reader035/viewer/2022062418/555ade69d8b42a024a8b51e5/html5/thumbnails/17.jpg)
• Currently, aches/pains, cough, colds, hyperacidity, minor topical infections and indigestion are major OTC categories.
• Emerging categories include cuts, wounds and burns, muscle pains and sprains, diarrhea and constipation.
![Page 18: OTC Markets in India 2008-09](https://reader035.fdocuments.net/reader035/viewer/2022062418/555ade69d8b42a024a8b51e5/html5/thumbnails/18.jpg)
• 'Prescription drugs' fall under two schedules of the Drug Rules, 1945 –
Schedule H and Schedule X.
• No separate list of OTC drugs
• What is not prohibited is permitted. Thus, all the drugs which are not specified in the list of 'prescription drugs' must be considered as non-prescription drugs (or the OTC drugs).
![Page 19: OTC Markets in India 2008-09](https://reader035.fdocuments.net/reader035/viewer/2022062418/555ade69d8b42a024a8b51e5/html5/thumbnails/19.jpg)
• The Drug & Magic Remedies (Objectionable Advertisement) Act mentions a list of ailments for which no advertising is permitted.
• The DCGI’s office in collaboration with the Organisation of Pharmaceutical Producers of India (OPPI) -has released a Voluntary Code on OTC Advertising which is being followed by all OPPI member companies.
• There is also an OPPI Code of Pharmaceutical Marketing Practices, January 2007, based on the IFPMA code.
http://www.indiaoppi.com/OPPI%20Code%20of%20Marketing%202007.pdf
![Page 20: OTC Markets in India 2008-09](https://reader035.fdocuments.net/reader035/viewer/2022062418/555ade69d8b42a024a8b51e5/html5/thumbnails/20.jpg)
• digestives• antacids• antiflatulents• cold rubs and analgesic balms/creams• vitamins/tonics/health supplements (especially herbals) • medicated skin treatment• analgesic /cold tablets• antiseptic creams/liquids• glucose powders• cough liquids• throat lozenges• medicated dressings (band-aids)• baby gripe water.
![Page 21: OTC Markets in India 2008-09](https://reader035.fdocuments.net/reader035/viewer/2022062418/555ade69d8b42a024a8b51e5/html5/thumbnails/21.jpg)
• OTC Drug Marketing – Global Trends and Indian Experiences Ajith Paninchukunnath*
• The Emergence of India’s Pharmaceutical Industry and Implications for the U.S. Generic Drug Market-William Greene, U.S. International Trade Commission, May 2007
• India’s Rising Growth Potential- GS GLOBAL ECONOMIC WEBSITE Economic Research from the GS Institutional Portal at https://portal.gs.com
![Page 22: OTC Markets in India 2008-09](https://reader035.fdocuments.net/reader035/viewer/2022062418/555ade69d8b42a024a8b51e5/html5/thumbnails/22.jpg)
• Central Drugs Standard Control OrganizationDirectorate General of Health Services, Ministry of Health and Family Welfare, Government of India
• India OTC Profile 2008http://www.indiaoppi.com/India%20OTC%20Profile
%202008.pdf
• Census, Government of India
Economic survey-2008
![Page 23: OTC Markets in India 2008-09](https://reader035.fdocuments.net/reader035/viewer/2022062418/555ade69d8b42a024a8b51e5/html5/thumbnails/23.jpg)
• Healthcare in India-Emerging market report 2007
• OTC Marketing of DrugsVijay Bhangale*- International Marketing Conference on Marketing & Society, April, 2007, IIMK
Dr.Neelesh BhandariM.B.B.S (AFMC),M.D (Path)P.G.P in Human Rights
Advisor ( Medical Communications)Mark IV Animation Studios Pvt. Ltd.